Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2011
In vivo demonstration that alpha-synuclein oligomers are toxic
Beate Winner, Roberto Jappelli, Samir K Maji, et al.
Molecular Cell
|
July 31, 2010
Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death
Tomohiro Nakamura, Lei Wang, Catherine C L Wong, et al.
Nature Cell Biology
|
August 15, 2018
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
Robert J Nichols, Franziska Haderk, Carlos Stahlhut, et al.
Journal of Medicinal Chemistry
|
December 19, 2022
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors
G Leslie Burnett, Yu C Yang, James B Aggen, et al.
Science Translational Medicine
|
January 17, 2024
Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders
Julie C Ullman, Kevin T Mellem, Yannan Xi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2011
In vivo demonstration that alpha-synuclein oligomers are toxic
Beate Winner, Roberto Jappelli, Samir K Maji, et al.
Molecular Cell
|
July 31, 2010
Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death
Tomohiro Nakamura, Lei Wang, Catherine C L Wong, et al.
Nature Cell Biology
|
August 15, 2018
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
Robert J Nichols, Franziska Haderk, Carlos Stahlhut, et al.
Journal of Medicinal Chemistry
|
December 19, 2022
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors
G Leslie Burnett, Yu C Yang, James B Aggen, et al.
Science Translational Medicine
|
January 17, 2024
Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders
Julie C Ullman, Kevin T Mellem, Yannan Xi, et al.
Page
of 2